Cytogenetic profiling in myelodysplastic syndromes: Perspective on an Indian cohort
Journal of Hematology and Allied Sciences · 04.05.2026 · 6 · 177-178
DOI: 10.25259/jhas_24_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology and Allied Sciences, online erschienen am 04.05.2026. Verfasst von Kaustav Ghosh. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Cytogenetic profile of myelodysplastic syndrome: A retrospective study" (JHAS_81_2025) addresses a clinically important dimension of myelodysplastic syndromes (MDSs), which are clonal hematopoietic disorders characterized by cytopenias and risk of progression to acute myeloid leukemia, in which cytogenetic abnormalities play a central role in diagnosis, classification, and prognostic stratification, forming an integral component of risk assessment models such as the Revised International Prognostic Scoring System (IPSS-R).[1,2]
Zitieren
APA
Ghosh, K. (2026). Cytogenetic profiling in myelodysplastic syndromes: Perspective on an Indian cohort. Journal of Hematology and Allied Sciences, 6, 177-178. https://doi.org/10.25259/jhas_24_2026
Vancouver
Ghosh K. Cytogenetic profiling in myelodysplastic syndromes: Perspective on an Indian cohort. Journal of Hematology and Allied Sciences. 2026;6:177-178. doi:10.25259/jhas_24_2026
BibTeX
@article{Ghosh2026,
author = {Ghosh, Kaustav},
title = {Cytogenetic profiling in myelodysplastic syndromes: Perspective on an Indian cohort},
journal = {Journal of Hematology and Allied Sciences},
year = {2026},
volume = {6},
pages = {177--178},
doi = {10.25259/jhas_24_2026}
}
EUVIMED